Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >>

Healthcare

>>

Europe Digital Respiratory Solutions Market


Europe Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1356175 | Industry: Healthcare | Published On: 44040


Europe digital respiratory solutions market reached $2.75 million in 2019 and will grow by 35.9% annually over 2020-2026 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
Highlighted with 34 tables and 43 figures, this 106-page report “Europe Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
• Inhalers
• Nebulizers
Diagnostic Devices
• Spirometers
• Asthma Monitors
• Other Diagnostic Devices
Sensors and Apps

Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• COVID-19 Caused Diseases
• Other Diseases

Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction  6
1.1  Industry  Definition  and  Research  Scope  6
1.1.1  Industry  Definition  6
1.1.2  Research  Scope  7
1.2  Research  Methodology  10
1.2.1  Overview  of  Market  Research  Methodology  10
1.2.2  Market  Assumption  11
1.2.3  Secondary  Data  11
1.2.4  Primary  Data  11
1.2.5  Data  Filtration  and  Model  Design  13
1.2.6  Market  Size/Share  Estimation  14
1.2.7  Research  Limitations  15
1.3  Executive  Summary  16
2  Market  Overview  and  Dynamics  18
2.1  Market  Size  and  Forecast  18
2.1.1  Impact  of  COVID-19  on  the  Market  19
2.2  Major  Growth  Drivers  21
2.3  Market  Restraints  and  Challenges  26
2.4  Emerging  Opportunities  and  Market  Trends  29
2.5  Porter’s  Fiver  Forces  Analysis  33
3  Segmentation  of  Europe  Market  by  Product  Type  38
3.1  Market  Overview  by  Product  Type  38
3.2  Therapeutic  Devices  40
3.2.1  Inhalers  41
3.2.2  Nebulizers  42
3.3  Diagnostic  Devices  43
3.3.1  Spirometers  45
3.3.2  Asthma  Monitors  46
3.3.3  Other  Diagnostic  Devices  47
3.4  Sensors  and  Apps  48
4  Segmentation  of  Europe  Market  by  Indication  49
4.1  Market  Overview  by  Indication  49
4.2  Asthma  51
4.3  Chronic  Obstructive  Pulmonary  Disease  (COPD)  52
4.4  COVID-19  Caused  Diseases  53
4.5  Other  Diseases  54
5  Segmentation  of  Europe  Market  by  Distribution  Channel  55
5.1  Market  Overview  by  Distribution  Channel  55
5.2  Hospital  Pharmacies  57
5.3  Retail  Pharmacies  58
5.4  Online  Pharmacies  59
6  European  Market  2019-2030  by  Country  60
6.1  Overview  of  European  Market  60
6.2  Germany  63
6.3  UK  65
6.4  France  68
6.5  Spain  70
6.6  Italy  72
6.7  Russia  74
6.8  Rest  of  European  Market  76
7  Competitive  Landscape  78
7.1  Overview  of  Key  Vendors  78
7.2  New  Product  Launch,  Partnership,  Investment,  and  M&A  81
7.3  Company  Profiles  82
3M  Health  Care  Limited  82
Adherium  Limited  84
Amiko  Digital  Health  Limited  85
AsthmaMD  86
AstraZeneca  plc  87
Boehringer  Ingelheim  International  GmbH  88
Capsule  Technologies,  Inc.  89
Cohero  Health  90
GlaxoSmithKline  plc  91
Kaia  Health  Software  GmbH  92
Medical  International  Research  (MIR)  93
Novartis  AG  94
NuvoAir  95
Reciprocal  Labs  (Propeller  Health)  96
Sensiron  AG  97
Tactio  Health  98
Teva  Pharmaceuticals  Industries  Ltd.  99
8  Investing  in  Europe  Market:  Risk  Assessment  and  Management  100
8.1  Risk  Evaluation  of  Europe  Market  100
8.2  Critical  Success  Factors  (CSFs)  103
Related  Reports  and  Products  106
Table 1. Snapshot of Europe Digital Respiratory Solutions Market, 2019-2030 17
Table 2. Main Product Trends and Market Opportunities in Europe Digital Respiratory Solutions Market 29
Table 3. Europe Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 38
Table 4. Europe Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 40
Table 5. Europe Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 44
Table 6. Europe Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 49
Table 7. Europe Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 55
Table 8. Europe Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 62
Table 9. Germany Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 64
Table 10. Germany Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 64
Table 11. Germany Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 64
Table 12. UK Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 67
Table 13. UK Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 67
Table 14. UK Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 67
Table 15. France Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 69
Table 16. France Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 69
Table 17. France Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 69
Table 18. Spain Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 71
Table 19. Spain Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 71
Table 20. Spain Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 71
Table 21. Italy Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 73
Table 22. Italy Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 73
Table 23. Italy Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 73
Table 24. Russia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 75
Table 25. Russia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 75
Table 26. Russia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 75
Table 27. Digital Respiratory Solutions Market in Rest of Europe by Country, 2019-2030, $ mn 77
Table 28. 3M Health Care Limited: Company Snapshot 82
Table 29. 3M Health Care Limited: Business Segmentation 82
Table 30. 3M Health Care Limited: Product Portfolio 83
Table 31. 3M Health Care Limited: Revenue, 2016-2018, $ mn 83
Table 32. 3M Health Care Limited: Recent Developments 83
Table 33. Risk Evaluation for Investing in Europe Market, 2019-2030 101
Table 34. Critical Success Factors and Key Takeaways 104

 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT